Impact of COPD severity on physical disability and daily living activities: EDIP-EPOC i and EDIP-EPOC II studies

International Journal of Clinical Practice

Volumn 63, Issue 5, 2009, Pages 742-750

  Rodriguez Gonzalez Moro, J M ^a   De Lucas Ramos, P ^a   Izquierdo Alonso, J L ^b   Lopez Muniz Ballesteros B ^a   Anton Diaz E ^c   Ribera, X ^a,d   Martin A ^c  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^c PFIZER INC   (United States)

^d Boehringer Ingelheim SCV   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE SEVERITY; ECONOMIC ASPECT; FAMILY ATTITUDE; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL DISABILITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; WORK;

ACTIVITIES OF DAILY LIVING; AGED; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DISABLED PERSONS; FAMILY HEALTH; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SICK LEAVE; VITAL CAPACITY;

EID: 64149108074     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2009.02040.x     Document Type: Article

References (39)

1. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med 1995 152 (5 Pt 2 S77 121.
2. Viegi G, Scognamiglio A, Baldacci S, Pistelli F, Carrozzi L. Epidemiology of chronic obstructive pulmonary disease (COPD). Respiration 2001 68 : 4 19.
3. Woolf CR, Zamel N. The respiratory effects of regular cigarette smoking in women. A five-year prospective study. Chest 1980 78 : 707 13.
4. Mittman C, Lieberman J, Marasso F, Miranda A. Smoking and chronic obstructive lung disease in alpha-1-antitrypsin deficiency. Chest 1971 60 : 214 21.
5. Hutchison DC, Cook PJ, Barter CE, Harris H, Hugh-Jones P. Pulmonary emphysema and alpha 1-antitrypsin deficiency. Br Med J 1971 1 : 689 94.
6. Petty TL, Brink GA, Miller MW, Corsello PR. Objective functional improvement in chronic airway obstruction. Chest 1970 57 (3 216 23.
7. Alvarez-Sala J, Cimas E, Masa J et al. Recommendations for the care of the patient with chronic obstructive pulmonary disease. Arch Bronconeumol 2001 37 : 269 78.
8. Lindberg A, Bjerg A, Ronmark E, Larsson LG, Lundback B. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2006 100 : 264 72.
9. Sobradillo V, Miravitlles M, Jimenez CA et al. Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): prevalence of chronic respiratory symptoms and airflow limitation. Arch Bronconeumol 1999 35 : 159 66.
10. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997 349 : 1498 504.
11. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI-WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001 163 : 1256 76.
12. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006 28 : 523 32.
13. Pena VS, Miravitlles M, Gabriel R et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000 118 : 981 9.
14. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD. 2006 http://www.goldcopd.org (accessed 1 June 2008).
15. Dal Negro RW, Tognella S, Tosatto R, Dionisi M, Turco P, Donner CF. Costs of chronic obstructive pulmonary disease (COPD) in Italy: the SIRIO study (social impact of respiratory integrated outcomes). Respir Med 2008 102 : 92 101.
16. Cicutto LC, Brooks D. Self-care approaches to managing chronic obstructive pulmonary disease: a provincial survey. Respir Med 2006 100 : 1540 6.
17. Janssen DJ, Wouters EF, Schols JM, Spruit MA. Self-perceived symptoms and care needs of patients with severe to very severe chronic obstructive pulmonary disease, congestive heart failure or chronic renal failure and its consequences for their closest relatives: the research protocol. BMC Palliat Care 2008 7 : 5.
18. Schreiner AS, Morimoto T, Arai Y, Zarit S. Assessing family caregiver's mental health using a statistically derived cut-off score for the Zarit Burden Interview. Aging Ment Health 2006 10 : 107 11.
19. Vitacca M, Escarrabill J, Galavotti G et al. Home mechanical ventilation patients: a retrospective survey to identify level of burden in real life. Monaldi Arch Chest Dis 2007 67 : 142 7.
20. Peruzza S, Sergi G, Vianello A et al. Chronic obstructive pulmonary disease (COPD) in elderly subjects: impact on functional status and quality of life. Respir Med 2003 97 : 612 7.
21. Carrasco Garrido P, de Miguel Diez J, Rejas Gutierrez J et al. Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health Qual Life Outcomes 2006 4 : 31.
22. Okubadejo AA, Jones PW, Wedzicha JA. Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia. Thorax 1996 51 : 44 7.
23. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999 54 : 581 6.
24. Gallego MC, Samaniego J, Alonso J, Sanchez A, Carrizo S, Marin JM. Dyspnea in COPD: relation to the MRC scale with dyspnea induced by walking and cardiopulmonary stress testing. Arch Bronconeumol 2002 38 : 112 6.
25. Vilaro J, Gimeno E, Sanchez Ferez N et al. Daily living activity in chronic obstructive pulmonary disease: validation of the Spanish version and comparative analysis of 2 questionnaires. Med Clin (Barc) 2007 129 : 326 32.
26. Garrod R, Bestall JC, Paul EA, Wedzicha JA, Jones PW. Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL). Respir Med 2000 94 : 589 96.
27. Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992 30 : 473 83.
28. Badia X, Salamero M, Alonso J. La medida de la salud. Guía de escalas de medición en español, 3rd edn. Barcelona : Edimac con Fundación Lilly, 2002.
29. Badia X, Roset M, Montserrat S, Herdman M, Segura A. The Spanish version of EuroQol: a description and its applications. European Quality of Life scale. Med Clin (Barc) 1999 112 (Suppl. 1 79 85.
30. Hur J, Kim TH, Kim SJ, Ryu YH, Kim HJ. Assessment of the right ventricular function and mass using cardiac multi-detector computed tomography in patients with chronic obstructive pulmonary disease. Korean J Radiol 2007 8 : 15 21.
31. Ottenheijm CA, Jenniskens GJ, Geraedts MC et al. Diaphragm dysfunction in chronic obstructive pulmonary disease: a role for heparan sulphate? Eur Respir J 2007 30 : 80 9.
32. Ottenheijm CA, Heunks LM, Dekhuijzen PN. Diaphragm muscle fiber dysfunction in chronic obstructive pulmonary disease: toward a pathophysiological concept. Am J Respir Crit Care Med 2007 175 : 1233 40.
33. Terzano C, Ceccarelli D, Conti V, Graziani E, Ricci A, Petroianni A. Maximal respiratory static pressures in patients with different stages of COPD severity. Respir Res 2008 9 : 8.
34. Baraldo S, Bazzan E, Zanin ME et al. Matrix metalloproteinase-2 protein in lung periphery is related to COPD progression. Chest 2007 132 : 1733 40.
35. Braido F, Riccio AM, Guerra L et al. Clara cell 16 protein in COPD sputum: a marker of small airways damage? Respir Med 2007 101 : 2119 24.
36. Benfield T, Lange P, Vestbo J. Chronic obstructive pulmonary disease stage and risk of hospitalization for infectious disease. Chest 2008 134 : 46 53.
37. Punekar YS, Rodriguez-Roisin R, Sculpher M, Jones P, Spencer M. Implications of chronic obstructive pulmonary disease (COPD) on patients' health status: a western view. Respir Med 2007 101 : 661 9.
38. Soyyigit S, Erk M, Guler N, Kilinc G. The value of SF-36 questionnaire for the measurement of life quality in chronic obstructive pulmonary disease. Tuberk Toraks 2006 54 : 259 66.
39. Miravitlles M, Calle M, Alvarez-Gutierrez F, Gobartt E, Lopez F, Martin A. Exacerbations, hospital admissions and impaired health status in chronic obstructive pulmonary disease. Qual Life Res 2006 15 : 471 80.